A summary of the key achievements between October and December 2015 is provided below:

• Scale-up of integrated HIV services had reached the following number of sites:

  • 724 static (579 within and 145 outside of health facilities) and 188 outreach HTC sites

  • 716 (static) ART sites

  • 617 PMTCT sites (Option B+, all included in ART sites above)

  • 668 Pre-ART sites

  • 652 sites with HIV-exposed child follow-up

• 604,854 persons were tested for HIV and received their results; 172,574 (29%) accessed HTC for the first time; 432,280 (71%) were repeat testers and 15,096 (3%) of these received confirmatory testing (after having tested positive in the past). This is equivalent to 63% confirmatory testing coverage among 24,082 patients initiating ART this quarter. 32,762 (5%) clients received a positive result for the first time.

• 23,692 (>99.9%) of 23,699 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

• 137,394 (92%) of 149,627 women at ANC had their HIV status ascertained; 10,613 (8%) of these were HIV positive. 122,523 (98%) of 125,204 women at maternity had their HIV status ascertained 9,102 (7%) of these were HIV positive.

• 24,082 patients started ART this quarter.

• 595,186 patients were alive and on ART by end of December 2015. This means that 60% of the estimated 1 million HIV positive population was on ART. 1 Estimated ART coverage among people in need for treatment1 was 51% (51,105 / 101,000) for children (<15 years) and 69% (540,071 / 779,000) for adults.

• 76% of adults and 77% of children were retained alive on ART at 12 months after initiation. Actual retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention analysis. (see section 15.4)

• 517,346 (93%) of 583,674 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).

• 76%, 69%, 66% and 65% of women started under Option B+ were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

• 8,748 (8%) of infants discharged alive from maternity were known to be HIV exposed, 7,872 (90%) of these received ARV prophylaxis (nevirapine). 7,131 (82%) were enrolled in exposed child followup before age 2 months.

• A total of 10,624 HIV exposed children and 5,650 pre-ART patients were enrolled for follow-up in HIV Care Clinics (HCC) during this quarter.